HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET

人类转录因子免疫原:全套的生成

基本信息

  • 批准号:
    8146979
  • 负责人:
  • 金额:
    $ 98.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-23 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of the proposed project is to assemble a collection of optimized immunogens based on the complete set of human transcription factors. These immunogens will be used by others to create renewable affinity reagents such as monoclonal antibodies. An initial, high priority application envisioned for such reagents is chromatin immunoprecipitation studies, and our aim is to design our immunogens so as to optimize them for this purpose. We will do this primarily using two strategies: (a) we will express transcription factor domains that flank the DNA recognition domain but do not overlap it in order to minimize inducing antibodies that might interfere with chromatin binding; and (b) wherever possible we will focus on transcription factor flanking domains that fold into complex three dimensional structures (native folds) and thus present highly specific 3D epitopes. We already have a protein production pipeline up and running that is producing > 1000 purified protein samples (including hundreds of human proteins) per year at the multi- milligram scale, so we are highly experienced in the relevant technologies, and meeting the goals of this FOA will require adding only a modest amount of extra capacity. We also have specialized software tools for the sophisticated analysis of human transcription factor sequences and the design of appropriate expression constructs. Our experience has shown that paying attention to the proper curation of genes and construct design at the beginning pays dividends downstream in terms of timely and cost-effective protein production because it minimizes wasting expensive wet lab resources on sub-par targets. Finally, we have a range of adaptable expression technologies that can be tailored to other classes of human protein targets (including secreted and membrane-bound proteins) in the future, so our approach is highly amenable to expressing additional sectors of the human proteome beyond transcription factors. RELEVANCE: The human genome project gave us a complete blueprint for the genetic instructions that control human biology. This proposal concerns a special set of human proteins known as "transcription factors", which are the master effector proteins in the cell that have the job of interpreting these instructions and telling the cell what to do under all sets of conditions. In diseases such as cancer these instructions can become garbled, which is why it is important to understand how transcription factors work. This proposal concerns the creation of a specific collection of human transcription factor-derived proteins that will allow scientists to precisely interrogate which transcription factors address which sets of instructions under a variety of conditions, thus establishing the outlines of the master control circuits in human cells.
描述(由申请人提供):拟议项目的目的是根据完整的人类转录因子集合一组优化的免疫原子。这些免疫原子将被其他人使用来创建可再生的亲和力试剂,例如单克隆抗体。染色质免疫沉淀研究是针对此类试剂的初始优先级应用,我们的目的是设计我们的免疫原子,以便为此目的优化它们。我们将主要使用两种策略来做到这一点:(a)我们将表达侧翼DNA识别域但不重叠的转录因子域,以最大程度地减少可能干扰染色质结合的抗体; (b)在可能的情况下,我们将重点放在折叠成复杂的三维结构(天然折叠)的转录因子侧面侧面域,从而呈现高度特定的3D表位。我们已经有一个蛋白质生产管道启动和运行,该管道每年在多毫克量表上每年生产> 1000个纯化的蛋白质样品(包括数百种人类蛋白质),因此我们在相关技术方面经验丰富,并且实现该FOA的目标将需要仅增加一定数量的额外容量。我们还拥有专门的软件工具,用于对人类转录因子序列进行复杂分析和适当表达构建体的设计。我们的经验表明,关注基因的适当策划和构造设计在一开始就在及时且具有成本效益的蛋白质生产方面向下游付费,因为它可以最大程度地减少浪费昂贵的湿实验室资源对低于标准的目标。最后,我们有一系列适应性的表达技术,这些技术可以在未来针对其他类别的人类蛋白质靶标(包括分泌和膜结合的蛋白质)量身定制,因此我们的方法高度适合表达人类蛋白质组的其他领域,超出转录因子。 相关性:人类基因组项目为我们的控制人类生物学的遗传指示提供了完整的蓝图。该提案涉及一组被称为“转录因子”的特殊人蛋白,它们是细胞中的主效应蛋白,具有解释这些指示并告诉细胞在所有条件下该怎么做的工作。在诸如癌症之类的疾病中,这些指示可能会乱七八糟,这就是为什么了解转录因子的工作原理很重要的原因。该提案涉及创建特定人类转录因子衍生蛋白的特定集合,这些蛋白质将使科学家能够精确询问哪些转录因子解决了哪些条件下的指令集,从而确立了人类细胞中主控制电路的轮廓。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

暂无数据

数据更新时间:2024-06-01

Stephen Anderson的其他基金

HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
人类转录因子免疫原:全套的生成
  • 批准号:
    8904907
    8904907
  • 财政年份:
    2010
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
人类转录因子免疫原:全套的生成
  • 批准号:
    8755145
    8755145
  • 财政年份:
    2010
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
人类转录因子免疫原:全套的生成
  • 批准号:
    8067553
    8067553
  • 财政年份:
    2010
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
人类转录因子免疫原:全套的生成
  • 批准号:
    8532451
    8532451
  • 财政年份:
    2010
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
人类转录因子免疫原:全套的生成
  • 批准号:
    8305707
    8305707
  • 财政年份:
    2010
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:

相似国自然基金

基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
  • 批准号:
    32360190
  • 批准年份:
    2023
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
  • 批准号:
    82304698
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
  • 批准号:
    62302456
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
  • 批准号:
    32301185
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
  • 批准号:
    32370941
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Novel approach to identify RNA-bound small molecules in vivo
体内鉴定 RNA 结合小分子的新方法
  • 批准号:
    10646626
    10646626
  • 财政年份:
    2023
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
  • 批准号:
    10667971
    10667971
  • 财政年份:
    2023
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
Supplement for Role of Environmental Weathering and Gastrointestinal Digestion on the Bioavailability and Toxicity of Microplastic and Cadmium Mixtures
补充环境风化和胃肠消化对微塑料和镉混合物的生物利用度和毒性的作用
  • 批准号:
    10854398
    10854398
  • 财政年份:
    2023
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
  • 批准号:
    10725416
    10725416
  • 财政年份:
    2023
  • 资助金额:
    $ 98.64万
    $ 98.64万
  • 项目类别: